Target Price | $6.84 |
Price | $2.60 |
Potential |
162.95%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Quipt Home Medical Corp - Ordinary Shares New 2025 .
The average Quipt Home Medical Corp - Ordinary Shares New target price is $6.84.
This is
162.95%
register free of charge
$12.00
361.54%
register free of charge
$4.00
53.85%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Quipt Home Medical Corp - Ordinary Shares New to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Quipt Home Medical Corp - Ordinary Shares New stock has an average upside potential 2025 of
162.95%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 245.92 | 254.00 |
16.18% | 3.29% | |
EBITDA Margin | 19.56% | 22.92% |
1.17% | 17.16% |
3 Analysts have issued a sales forecast Quipt Home Medical Corp - Ordinary Shares New 2025 . The average Quipt Home Medical Corp - Ordinary Shares New sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Quipt Home Medical Corp - Ordinary Shares New EBITDA forecast 2025. The average Quipt Home Medical Corp - Ordinary Shares New EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | 0.77 |
Based on analysts' sales estimates for 2025, the Quipt Home Medical Corp - Ordinary Shares New stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Quipt Home Medical Corp - Ordinary Shares New...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.